Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Online ISSN : 1882-5133
Print ISSN : 1345-2843
ISSN-L : 1345-2843
Case Reports
Three Cases of Lung Metastases from Pancreatic Cancer Performed Lung Resection
Masatoshi KANAYAMA, Toshihiro OSAKI, Natsumasa NISHIZAWA, Makoto NAKAGAWA, Mantaro KODATE, Kiyoshi KAJIYAMA
Author information
JOURNAL FREE ACCESS

2016 Volume 77 Issue 5 Pages 1062-1068

Details
Abstract
We report three cases of lung metastses from pancreatic cancer performed lung resection. The first case involved a 73-year-old woman. She underwent right wedge resection for three lung metastases 2 years 2 months after the surgical resection of pancreatic carcinoma, followed by left lower lung wedge resection and left lower lobectomy for lung metastases, 4 years 2 months and 5 years 9 months after the resection of pancreatic cancer, respectively. In the course of her treatment, she maintained on chemotherapy (gemcitabine : 57 courses). The patient has been alive without tumor relapse as of 7 years 8 months after the initial pancreatic resection. The second case involved a 76-year-old man. He underwent right wedge resection for three lung metastases 1 year 8 months after the surgical resection of pancreatic carcinoma, followed by left lower lung wedge resection for lung metastasis 2 years 1 month after the resection of pancreatic cancer. In the course of his treatment, he maintained on chemotherapy (gemcitabine : 32 courses). The patient has been alive without tumor relapse as of 2 years 11 months after the initial pancreatic resection. The third case involved a 71-year-old woman. She underwent bilateral wedge resections for three lung metastases (right : one, left : two) on a two-step approach 2 years after the surgical resection of pancreatic carcinoma. In the course of her treatment, she maintained on chemotherapy (gemcitabine : 48 courses). The patient has been alive without tumor relapse as of 3 years 2 months after the initial pancreatic resection. Aggressive pulmonary resection and the maintained chemotherapy may contribute to improvement of prognosis.
Content from these authors
© 2016 Japan Surgical Association
Previous article Next article
feedback
Top